Market Research Logo

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sangamo BioSciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Sangamo BioSciences, Inc.
  • The report provides overview of Sangamo BioSciences, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Sangamo BioSciences, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Sangamo BioSciences, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Sangamo BioSciences, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Sangamo BioSciences, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Sangamo BioSciences, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Sangamo BioSciences, Inc. Snapshot
Sangamo BioSciences, Inc. Overview
Key Information
Key Facts
Sangamo BioSciences, Inc. - Research and Development Overview
Key Therapeutic Areas
Sangamo BioSciences, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Sangamo BioSciences, Inc. - Pipeline Products Glance
Sangamo BioSciences, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Sangamo BioSciences, Inc. - Early Stage Pipeline Products
IND/CTA Filed Products/Combination Treatment Modalities
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Sangamo BioSciences, Inc. - Drug Profiles
SB-728T
Product Description
Mechanism of Action
R&D Progress
SB-728HSPC
Product Description
Mechanism of Action
R&D Progress
SB-FIX
Product Description
Mechanism of Action
R&D Progress
SB-318
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Beta Thalassemia
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Sickle Cell Disease
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for X-Linked SCID
Product Description
Mechanism of Action
R&D Progress
Gene Therapy to Activate Alpha-1 Antitrypsin for Alpha-Antitrypsin Deficiency
Product Description
Mechanism of Action
R&D Progress
Gene Therapy to Active Pulmonary Surfactant-Associated Protein B for Lung Diseases
Product Description
Mechanism of Action
R&D Progress
Gene Therapy to Inhibit Huntingtin Protein for Huntington’s Disease
Product Description
Mechanism of Action
R&D Progress
SB-913
Product Description
Mechanism of Action
R&D Progress
SB-FVIII
Product Description
Mechanism of Action
R&D Progress
SBLSD-3
Product Description
Mechanism of Action
R&D Progress
SBLSD-4
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Monogenic Diseases
Product Description
Mechanism of Action
R&D Progress
Sangamo BioSciences, Inc. - Pipeline Analysis
Sangamo BioSciences, Inc. - Pipeline Products by Target
Sangamo BioSciences, Inc. - Pipeline Products by Route of Administration
Sangamo BioSciences, Inc. - Pipeline Products by Molecule Type
Sangamo BioSciences, Inc. - Pipeline Products by Mechanism of Action
Sangamo BioSciences, Inc. - Recent Pipeline Updates
Sangamo BioSciences, Inc. - Dormant Projects
Sangamo BioSciences, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
CERE-110
CERE-120
SB-509
Sangamo BioSciences, Inc. - Company Statement
Sangamo BioSciences, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sangamo BioSciences, Inc., Key Information
Sangamo BioSciences, Inc., Key Facts
Sangamo BioSciences, Inc. - Pipeline by Indication, 2016
Sangamo BioSciences, Inc. - Pipeline by Stage of Development, 2016
Sangamo BioSciences, Inc. - Monotherapy Products in Pipeline, 2016
Sangamo BioSciences, Inc. - Phase II, 2016
Sangamo BioSciences, Inc. - Phase I, 2016
Sangamo BioSciences, Inc. - IND/CTA Filed, 2016
Sangamo BioSciences, Inc. - Preclinical, 2016
Sangamo BioSciences, Inc. - Discovery, 2016
Sangamo BioSciences, Inc. - Pipeline by Target, 2016
Sangamo BioSciences, Inc. - Pipeline by Route of Administration, 2016
Sangamo BioSciences, Inc. - Pipeline by Molecule Type, 2016
Sangamo BioSciences, Inc. - Pipeline Products by Mechanism of Action, 2016
Sangamo BioSciences, Inc. - Recent Pipeline Updates, 2016
Sangamo BioSciences, Inc. - Dormant Developmental Projects,2016
Sangamo BioSciences, Inc. - Discontinued Pipeline Products, 2016
Sangamo BioSciences, Inc., Subsidiaries
List of Figures
Sangamo BioSciences, Inc. - Pipeline by Top 10 Indication, 2016
Sangamo BioSciences, Inc. - Pipeline by Stage of Development, 2016
Sangamo BioSciences, Inc. - Monotherapy Products in Pipeline, 2016
Sangamo BioSciences, Inc. - Pipeline by Target, 2016
Sangamo BioSciences, Inc. - Pipeline by Route of Administration, 2016
Sangamo BioSciences, Inc. - Pipeline by Molecule Type, 2016
Sangamo BioSciences, Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report